S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 AVROBIOAptose BiosciencesAutolus TherapeuticsMeiraGTxProteon Therapeutics
SymbolNASDAQ:AVRONASDAQ:APTONASDAQ:AUTLNASDAQ:MGTXNASDAQ:PRTO
Price Information
Current Price$14.00$6.13$10.58$13.73$24.42
52 Week RangeBuyBuyBuyBuyN/A
Beat the Market™ Rank
Overall Score1.91.41.21.40.8
Analysis Score4.43.53.53.50.0
Community Score2.82.72.42.92.6
Dividend Score0.00.00.00.00.0
Ownership Score1.70.80.00.80.8
Earnings & Valuation Score0.60.00.00.00.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyN/A
Consensus Price Target$32.17$11.29$27.33$34.40N/A
% Upside from Price Target129.76% upside84.11% upside158.35% upside150.55% upsideN/A
Trade Information
Market Cap$510.31 million$544.72 million$475.92 million$527.40 million$541.61 million
Beta1.631.522.021.380.6
Average Volume292,154949,589155,912122,7531,113,217
Sales & Book Value
Annual RevenueN/AN/A$2.91 million$13.29 millionN/A
Price / SalesN/AN/A163.5539.68N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$5.70 per share$1.45 per share$5.26 per share$5.22 per share($0.06) per share
Price / BookN/AN/A2.012.63N/A
Profitability
Net Income$-72,960,000.00$-26,280,000.00$-123,850,000.00$-54,750,000.00$-20,730,000.00
EPS($2.66)($0.52)($2.88)($1.65)($1.15)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/A-8,652.90%-331.44%N/A
Return on Equity (ROE)-51.33%-49.53%-54.01%-30.69%N/A
Return on Assets (ROA)-47.65%-46.65%-44.19%-18.45%-118.68%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/A0.11%N/A
Current Ratio9.14%24.60%7.43%5.03%5.98%
Quick Ratio9.14%24.60%7.43%5.03%5.98%
Ownership Information
Institutional Ownership Percentage81.20%41.84%30.26%54.54%23.03%
Insider Ownership Percentage4.78%6.30%N/A16.50%45.70%
Miscellaneous
Employees1233129020617
Shares Outstanding36.45 million88.86 million44.98 million38.41 million22.18 million
Next Earnings Date3/15/2021 (Estimated)3/9/2021 (Estimated)3/2/2021 (Estimated)3/10/2021 (Estimated)N/A
OptionableNot OptionableOptionableNot OptionableNot OptionableNot Optionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.